STE STERIS plc

254.76USD-1.85%Mkt Cap: 24.74B USDP/E: 30.22

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. Th…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap24.74B USD
Enterprise Value26.74B USD
Revenue (TTM)6.17B USD
Gross Profit2.63B USD
Net Income (TTM)782.30M USD
Revenue/Share63.08 USD
Last Price254.76 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees17.9K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)30.22
P/E (Forward)20.45
PEG2.53
EV/EBITDA15.94
EV/Revenue4.34
P/S4.01
P/B3.41
EPS (TTM)8.43 USD
EPS (Forward)12.46 USD
52W Range
195.1480% of range269.44
52W High269.44 USD
52W Low195.14 USD
Profitability
Gross Margin44.25%
Oper. Margin19.18%
EBITDA Margin27.21%
Profit Margin13.18%
ROE10.89%
ROA7.29%
ROIC9.37%
ROCE11.53%
Growth
Revenue Growth8.80%
Earnings Growth12.90%
Cash Flow & Leverage
Operating CF1.34B USD
CapEx (TTM)369.00M USD
FCF Margin13.34%
FCF Yield3.32%
Net Debt1.52B USD
Net Debt/EBITDA0.91
Net Debt/FCF1.85
Balance Sheet
Debt/Equity0.29
Current Ratio2.05
Quick Ratio1.27
Book Value/Sh74.74 USD
Cash/Share5.47 USD
Dividends
Fwd Div Rate2.76 USD
Trail. Div Rate2.58 USD
Div. Yield1.06%
5Y Avg Yield0.92%
Payout Ratio30.61%
Ex-Div DateNov 17, 2026
Pay DateDec 17, 2026
Splits
Last Split2:1
Split DateAug 25, 1998
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)281.14 USD
Upside (mean)+10.4%
Target Range244.00 USD – 305.00 USD
244.00+10.4% to mean305.00
# Analysts7
Ownership
Shares Out.97.11M
Float96.69M
Insiders0.31%
Institutions101.50%
Short Interest
Short Ratio3.1d
Short % Float2.25%
Short % Out.2.25%
Shares Short2.18M
Short (prev mo.)2.86M
Technical
SMA 50224.02 (+13.7%)
SMA 200224.13 (+13.7%)
Beta0.86
S&P 52W Chg12.08%
Avg Vol (30d)811.73K
Avg Vol (10d)1.02M
Technical Indicators
RSI (14)61.6
MACD9.6238
MACD Signal9.3849
MACD Hist.+0.2390
BB Upper272.98 USD
BB Middle245.98 USD
BB Lower218.98 USD
BB Width21.96%
ATR (14)6.517 USD
Vol Ratio (20d)1.04x

About STERIS (NYSE: STE)

›

STERIS (NYSE: STE) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 17,937 employees.

The shares were at 254.76 USD on 19 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 195.14 USD to 269.44 USD: the price is 5.4% below the high and 30.6% above the low.

At a market capitalisation of 24.74B USD, it trades at 30.2 times trailing earnings and 20.5 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.4, a premium of 19% for STE. It pays a dividend yielding 1.06% (it pays out 31% of its earnings), against a median of 2.41% among the dividend payers in that peer group.

STERIS reports return on equity of 10.9%, an operating margin of 19.2% and revenue up 8.8% year over year.

Its debt exceeds its cash by 1.52B USD, a debt-to-equity ratio of 0.29. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 7 analysts cover the stock, with an average rating of Buy; their mean price target of 281.14 USD is 10.4% above the current price. The next earnings report is expected on 3 February 2027.